Skip to content

IceCure Medical Ltd.: financial reference

Explore IceCure Medical Ltd. financial histories from SEC filings, with original units, reporting periods, filing dates and downloadable source data.

Reported financial histories

Choose a measure to inspect its definition, complete selected history and filing provenance. Each row shows the latest period available for that selected concept and original unit. Separate currencies and reporting intervals remain separate rows. Coverage dates can differ between concepts. A recent capture does not imply recent accounting coverage; these amounts are not prices.

Latest periods by selected concept and original unit
MeasurePeriod startPeriod endValueUnitFiled
Total assetsAt date2025-12-3113,888,000USD2026-03-17
Stockholders equityAt date2025-12-319,051,000USD2026-03-17
Cash and cash equivalentsAt date2025-12-318,897,000USD2026-03-17
Net income or loss2025-01-012025-12-31-15,057,000USD2026-03-17
Operating cash flow2025-01-012025-12-31-14,574,000USD2026-03-17
Capital expenditure payments2025-01-012025-12-3136,000USD2026-03-17
Revenue2025-01-012025-12-313,379,000USD2026-03-17
Financing cash flow2025-01-012025-12-3115,834,000USD2026-03-17
Investing cash flow2025-01-012025-12-31-36,000USD2026-03-17
Retained earnings or deficitAt date2025-12-31-120,436,000USD2026-03-17
Basic weighted-average shares2025-01-012025-12-3163,579,251shares2026-03-17
Diluted weighted-average shares2025-01-012025-12-3163,579,251shares2026-03-17
Basic earnings per share2025-01-012025-12-310.24USD/shares2026-03-17
Diluted earnings per share2025-01-012025-12-310.24USD/shares2026-03-17
Net property, plant and equipmentAt date2025-12-31993,000USD2026-03-17
Share-based compensation expense2025-01-012025-12-311,373,000USD2026-03-17
Operating income or loss2025-01-012025-12-31-15,094,000USD2026-03-17
Current assetsAt date2025-12-3112,605,000USD2026-03-17
Current liabilitiesAt date2025-12-314,824,000USD2026-03-17
Current accounts payableAt date2023-12-31502,000USD2024-04-03
Net current accounts receivableAt date2024-12-31221,000USD2025-03-27
Net inventoryAt date2025-12-312,625,000USD2026-03-17
Gross profit2025-01-012025-12-311,226,000USD2026-03-17
Cost of revenue2025-01-012025-12-312,153,000USD2026-03-17
Selling, general and administrative expense2022-01-012022-12-31735,000USD2023-03-29
Research and development expense2025-01-012025-12-317,433,000USD2026-03-17
Common shares outstandingAt date2025-12-3173,122,293shares2026-03-17
Cash including restricted cashAt date2025-12-318,897,000USD2026-03-17
Additional paid-in capitalAt date2024-12-31112,280,000USD2025-03-27
Total equity including noncontrolling interestsAt date2021-12-3126,958,000USD2022-08-22
Operating lease right-of-use assetAt date2025-12-31239,000USD2026-03-17
Operating lease liabilityAt date2025-12-31217,000USD2026-03-17
Gross property, plant and equipmentAt date2025-12-312,803,000USD2026-03-17
Accumulated depreciation on property, plant and equipmentAt date2025-12-311,810,000USD2026-03-17
Prepaid expenses and other current assetsAt date2025-12-31752,000USD2026-03-17
Profit or loss including noncontrolling interests2022-01-012022-12-31-16,978,000USD2023-03-29
General and administrative expense2025-01-012025-12-314,529,000USD2026-03-17
Depreciation expense2025-01-012025-12-31295,000USD2026-03-17
Nonoperating income or expense2025-01-012025-12-3137,000USD2026-03-17
Proceeds from issuing common stock2024-01-012024-12-319,187,000USD2025-03-27
Operating lease payments2025-01-012025-12-31351,000USD2026-03-17
Change in accounts receivable2025-01-012025-12-31110,000USD2026-03-17
Change in inventories2025-01-012025-12-31637,000USD2026-03-17

Filings

7 IceCure Medical Ltd. filings with published measures: what each annual or quarterly report tagged, with the periods it covered, as reported in that filing. The histories above show the latest-filed value per period.

Inspect the source

Entity
IceCure Medical Ltd. / CIK 0001584371
Captured
2026-09-20T09:23:08.891Z
SEC response SHA-256
69fc07cf0ed1e8ececccce3210c1ad2159bbe4ba65cf61ab2db13c22606b3528

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001584371.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))